Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Streptomyces fradiae is not itself used directly to treat bacterial infections, but it is a scientifically significant microorganism because it produces antibiotics used in the treatment of such infections. The most notable antibiotic produced by S. fradiae is neomycin, an aminoglycoside antibiotic. Neomycin was discovered in the 1940s and is widely used for its broad-spectrum activity against Gram-negative and some Gram-positive bacteria. It is commonly used topically in creams and ointments, and sometimes orally in specific circumstances, such as bowel decontamination before surgery.

The scientific evidence supporting the use of neomycin (and therefore the importance of S. fradiae) in treating infections is robust and well-documented. Numerous clinical studies and decades of medical use confirm its efficacy and safety profile, although its systemic use is limited due to potential nephrotoxicity and ototoxicity. Additionally, S. fradiae has been a model organism for the study of antibiotic biosynthesis.

In summary, while S. fradiae itself is not administered as a treatment, its role as the natural source of neomycin represents strong scientific validation for its indirect use in supporting the treatment of bacterial infections.

More about Streptomyces fradiae
More about Infection (bacterial)

Other ingredients used for Infection (bacterial)

Other health conditions supported by Streptomyces fradiae

Products containing Streptomyces fradiae